GB0720409D0 - Pharmaceutical formulation for treatment of acquired immune deficiency syndrome (AIDS). Obtaining procedure. - Google Patents

Pharmaceutical formulation for treatment of acquired immune deficiency syndrome (AIDS). Obtaining procedure.

Info

Publication number
GB0720409D0
GB0720409D0 GBGB0720409.2A GB0720409A GB0720409D0 GB 0720409 D0 GB0720409 D0 GB 0720409D0 GB 0720409 A GB0720409 A GB 0720409A GB 0720409 D0 GB0720409 D0 GB 0720409D0
Authority
GB
United Kingdom
Prior art keywords
aids
treatment
pharmaceutical formulation
immune deficiency
deficiency syndrome
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GBGB0720409.2A
Other versions
GB2443304A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Acosta Jose R B
Original Assignee
Acosta Jose R B
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acosta Jose R B filed Critical Acosta Jose R B
Priority to GB0720409A priority Critical patent/GB2443304A/en
Publication of GB0720409D0 publication Critical patent/GB0720409D0/en
Publication of GB2443304A publication Critical patent/GB2443304A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • AIDS & HIV (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GB0720409A 2007-10-18 2007-10-18 Pharmaceutical formulation for treatment of Acquired Immune Deficiency Syndrome (AIDS). Withdrawn GB2443304A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB0720409A GB2443304A (en) 2007-10-18 2007-10-18 Pharmaceutical formulation for treatment of Acquired Immune Deficiency Syndrome (AIDS).

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0720409A GB2443304A (en) 2007-10-18 2007-10-18 Pharmaceutical formulation for treatment of Acquired Immune Deficiency Syndrome (AIDS).

Publications (2)

Publication Number Publication Date
GB0720409D0 true GB0720409D0 (en) 2007-11-28
GB2443304A GB2443304A (en) 2008-04-30

Family

ID=38814391

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0720409A Withdrawn GB2443304A (en) 2007-10-18 2007-10-18 Pharmaceutical formulation for treatment of Acquired Immune Deficiency Syndrome (AIDS).

Country Status (1)

Country Link
GB (1) GB2443304A (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GT199800140A (en) * 1997-09-12 2000-02-29 ANTIMASTIC PHARMACEUTICAL COMPOSITION BASED ON EXTRACTS OF NATURAL ORIGIN AND PROCEDURES TO MANUFACTURE IT.

Also Published As

Publication number Publication date
GB2443304A (en) 2008-04-30

Similar Documents

Publication Publication Date Title
ZA200906126B (en) Use of IL-23 antigonists for treatment of infection
WO2012055567A3 (en) Use of malononitrilamides in neuropathic pain
IL225198A (en) Aminotetrahydropyran compounds, pharmaceutical compositions comprising the same and the use thereof for the treatment of diabetes
WO2012047856A3 (en) Novel inhibitors of secretion of hepatitis b virus antigens
IL209258A (en) Derivatives of pyrrolopyridines, pharmaceutical compositions comprising them, processes for their preparation and uses thereof
EP2222392A4 (en) Ultrasonic treatment chamber for preparing antimicrobial formulations
HK1156038A1 (en) Compounds and pharmaceutical compositions for the treatment of viral infections
EP2379079A4 (en) Pharmaceutical formulations comprising voriconazole and processes for preparation thereof
IL211314A0 (en) Pharmaceutical dosage forms comprising poly (?á-caprolactone)
PL2249816T3 (en) Formulation and method for the prevention and treatment of bone metastases or other bone diseases
PL2079446T3 (en) Paliperidone sustained release formulation
IL206815A (en) Cyclic triazo and diazo channel blockers, pharmaceutical compositions comprising them and use thereof for the preparation of medicaments for the treatment of diseases
ZA201001264B (en) 1-amino-alkylcycohxane derivatives for the treatment of cochleat tinnitus
WO2009114461A3 (en) Angiotensin (1-7) dosage forms and uses thereof
ZA201200017B (en) Formulations for the treatment of deeep tissue pain
WO2011150201A3 (en) Azolyl amide compounds and methods of use thereof
WO2011072069A3 (en) Gastric retentive pharmaceutical compositions for extended release of polypeptides
ZA201203281B (en) Pharmaceutical combinations, pharmaceutical compositions, medicament and method for the treatment of animals
IL217295A (en) (6-oxo-1,6 - dihydropyrimidin -2 - yl) amide derivatives, preparation thereof and pharmaceutical use thereof for the treatment of cancer
IL212942A (en) Rifamycin derivatives, process for their preparation, pharmaceutical compositions comprising the same and uses thereof
IL202450A (en) Pharmaceutical composition for the treatment of an influenza virus infection
EP1998811A4 (en) Eimmunotherapy for immune suppressed patients
PL2502635T3 (en) Combined formulations for the treatment of male infertility
GB0715790D0 (en) Drug combination for the treatment of sialorrhoea
WO2010148314A3 (en) Preparation of esomeprazole and its pharmaceutically acceptable salts

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)